In addition, given the presumed role of excessive VWF-platelet interaction in thrombocytopenia in severe leptospirosis, novel therapies aimed at preventing this interaction, including recombinant ADAMTS13 [66], might also have some therapeutic value. This evidence concerns the gene ADAMTS13 and Thrombocytopenia.